Raymond James & Associates’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$85.8K Buy
+10,739
New +$85.8K ﹤0.01% 3755